Table I.
Demographic characteristics and comorbidities of the cohort population
| N = 256 | |
|---|---|
| Age, years | 63.76 (±15) |
| Sex | |
| Female | 103 (40) |
| Male | 153 (60) |
| Ethnicity | |
| Caucasian | 3 (1) |
| Hispanic | 139 (54) |
| African American | 114 (45) |
| BMI, kg/m2 | 29.77 (±7) |
| Vaccination status | |
| None | 240 (93) |
| One dose | 3 (1) |
| Two doses | 13 (5) |
| Smoking | |
| Never | 192 (75) |
| Former | 20 (9) |
| Current | 10 (5) |
| Comorbidities | |
| Hypertension | 172 (67) |
| Diabetes mellitus | 132 (52) |
| COPD | 21 (8) |
| Asthma | 21 (8) |
| CAD/CHF | 54 (21) |
| Atrial fibrillation | 17 (6) |
| TIA/stroke | 10 (4) |
| Peripheral arterial disease | 7 (3) |
| CKD | 70 (27) |
| Active malignancy | 21 (8) |
| Immunosuppression | 31 (12) |
| Thrombophilia | 4 (1) |
| Previous DVT/PE | 24 (9) |
| Start of COVID-19 symptoms, daysa | 3 (1-7) |
BMI, Body mass index; CAD, coronary arterial disease; CHF, chronic heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; COVID-19, Coronavirus disease 2019; DVT, deep venous thrombosis; PE, pulmonary embolism; TIA, transient ischemic attack.
Data are presented as number (%), mean (standard deviation), or median (interquartile range).
a
Start of COVID symptoms in number of days prior to admission.